151 related articles for article (PubMed ID: 7958313)
1. Bacterial and host interactions during the biogenesis, toxicity and immunogenicity of Escherichia coli heat-labile enterotoxin.
Hirst TR; Nashar TO; Eaglestone S; Lencer WI; Webb HM; Yu J
Biochem Soc Trans; 1994 May; 22(2):306-9. PubMed ID: 7958313
[No Abstract] [Full Text] [Related]
2. Does enteropathogenic Escherichia coli produce heat-labile enterotoxin, heat-stable enterotoxins a or b, or cholera toxin A subunits?
Long-Krug SA; Weikel CS; Tiemens KT; Hewlett EL; Levine MM; Guerrant RL
Infect Immun; 1984 Nov; 46(2):612-4. PubMed ID: 6389354
[TBL] [Abstract][Full Text] [Related]
3. Importance of receptor binding in the immunogenicity, adjuvanticity and therapeutic properties of cholera toxin and Escherichia coli heat-labile enterotoxin.
Nashar TO; Williams NA; Hirst TR
Med Microbiol Immunol; 1998 Jun; 187(1):3-10. PubMed ID: 9749977
[No Abstract] [Full Text] [Related]
4. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.
Pizza M; Fontana MR; Giuliani MM; Domenighini M; Magagnoli C; Giannelli V; Nucci D; Hol W; Manetti R; Rappuoli R
J Exp Med; 1994 Dec; 180(6):2147-53. PubMed ID: 7964489
[TBL] [Abstract][Full Text] [Related]
5. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.
Rappuoli R; Pizza M; Douce G; Dougan G
Immunol Today; 1999 Nov; 20(11):493-500. PubMed ID: 10529776
[No Abstract] [Full Text] [Related]
6. Structural basis for the differential toxicity of cholera toxin and Escherichia coli heat-labile enterotoxin. Construction of hybrid toxins identifies the A2-domain as the determinant of differential toxicity.
Rodighiero C; Aman AT; Kenny MJ; Moss J; Lencer WI; Hirst TR
J Biol Chem; 1999 Feb; 274(7):3962-9. PubMed ID: 9933586
[TBL] [Abstract][Full Text] [Related]
7. Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines.
Glenn GM; Francis DH; Danielsen EM
Infect Immun; 2009 Dec; 77(12):5206-15. PubMed ID: 19737904
[TBL] [Abstract][Full Text] [Related]
8. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
Clements JD; Finkelstein RA
Infect Immun; 1978 Sep; 21(3):1036-9. PubMed ID: 361573
[TBL] [Abstract][Full Text] [Related]
9. Genetic detoxification of bacterial toxins.
Pizza M; Fontana MR; Scarlato V; Rappuoli R
Methods Mol Med; 2003; 87():133-52. PubMed ID: 12958454
[No Abstract] [Full Text] [Related]
10. Detection of heat-labile enterotoxin-producing Escherichia coli strains by a staphylococcal coagglutination technique.
Sen AK; Gulati AK; Agarwal RK; Sanyal SC
J Diarrhoeal Dis Res; 1984 Mar; 2(1):33-6. PubMed ID: 6389665
[No Abstract] [Full Text] [Related]
11. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes.
Negri DR; Pinto D; Vendetti S; Patrizio M; Sanchez M; Riccomi A; Ruggiero P; Del Giudice G; De Magistris MT
Infect Immun; 2009 May; 77(5):1924-35. PubMed ID: 19223474
[TBL] [Abstract][Full Text] [Related]
12. [The gastrointestinal immune system: cholera toxin and E. coli heat-labile enterotoxin as immunomodulators].
Kim J; Kiyono H
Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):547-55. PubMed ID: 11268659
[No Abstract] [Full Text] [Related]
13. Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites.
Rigano MM; Sala F; Arntzen CJ; Walmsley AM
Vaccine; 2003 Jan; 21(7-8):809-11. PubMed ID: 12531365
[TBL] [Abstract][Full Text] [Related]
14. [Method for the detection and determination of heat-labile Escherichia coli enterotoxin by an immunoenzyme technic on a new polystyrene support adapted for a test kit].
Germani Y; Begaud E; Dassy B; Legonidec G; Guesdon JL
Ann Microbiol (Paris); 1984; 135B(3):297-310. PubMed ID: 6398008
[TBL] [Abstract][Full Text] [Related]
15. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
Connell TD
Expert Rev Vaccines; 2007 Oct; 6(5):821-34. PubMed ID: 17931161
[TBL] [Abstract][Full Text] [Related]
16. Antigenic determinants of the cholera/coli family of enterotoxins.
Finkelstein RA; Burks MF; Zupan A; Dallas WS; Jacob CO; Ludwig DS
Rev Infect Dis; 1987; 9 Suppl 5():S490-502. PubMed ID: 2446368
[TBL] [Abstract][Full Text] [Related]
17. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.
de Haan L; Verweij W; Agsteribbe E; Wilschut J
Immunol Cell Biol; 1998 Jun; 76(3):270-9. PubMed ID: 9682971
[TBL] [Abstract][Full Text] [Related]
18. Estimation of Vibrio cholerae and Escherichia coli heat-labile enterotoxin by enzyme-linked immunosorbent assay (ELISA).
Kétyi I; Pácsa AS
Acta Microbiol Acad Sci Hung; 1980; 27(1):89-97. PubMed ID: 6998259
[TBL] [Abstract][Full Text] [Related]
19. Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.
Jacob CO; Arnon R; Finkelstein RA
Infect Immun; 1986 May; 52(2):562-7. PubMed ID: 3009330
[TBL] [Abstract][Full Text] [Related]
20. Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat-labile enterotoxin.
Cieplak W; Messer RJ; Konkel ME; Grant CC
Mol Microbiol; 1995 May; 16(4):789-800. PubMed ID: 7476173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
